Dr. @ertrunnell.bsky.social thanks for posting. While there is much yet to do, think in not too distant future #GigaTIME will have a major impact in tailoring therapies to patients with #cancer #GSK #Astrazeneca #Regeneron #Abbvie #incyte #FDA #NCI #FinishCancer
No Streams this weekend.
I'll be dying in the heat for an amazing cause.
I'm excited to say this will be my 3rd year participating in the Portland to Coast relay, a 128-mile race that supports the Providence Cancer Institute.
Wish me luck!
#FINISHCANCER
hoodtocoast.com/community-im...
Prof. Richard Wahl redefines #Theranostics & shows how #PET can be used to identify response and prevent over-treatment #Malinckodt #Institute of #Radiology #FinishCancer #ASTRO2025
More #THERANOSTICS -
Prof Richard Wahl #MalinckrodtInstitute #MIR gives a bit more history on the topic. 1st iodine-labelled #monoclonal #antibodies. #FDG #ASTRO2025 #FinishCancer @uwiscradiology.bsky.social
#Theranostics can cure some patients? Here is an example of a patient with metastatic #ThyroidCancer that has long-term disease-free survival / @mskcancercenter.bsky.social #ASTRO2025 #FinishCancer
THERANOSTICS
WHAT IS IT? Answer below..
Why should you care?? It is improving outcomes for men with #prostate #cancer - #Pluvicto
#Bayer #Novartis #FinishCancer #ASTRO2025 #PCF @prostatecanceruk.bsky.social @ipcr.bsky.social @ip-london.bsky.social #CRUK @cruk-mi.bsky.social @prostates.bsky.social
🧐???? #THERANOSTICS ????
Looking forward to hearing the first two keynotes at THERANOSTICS conference being held at the new #Discovery building at @uwiscradiology.bsky.social @uwiscpress.bsky.social
#cancer #radiation #Therapy #ASTRO #FinishCancer #Pluvicto #Novartis #PCF #ProstateCancer
Beautiful way to close out a spectacular day at #AACR2025. Thank you for sharing this inspiring message Dr. Fox! #FinishCancer #cure #cancer
💥🦊🎶 WORK HARD/PLAY HARD! Today at #AACR2025 was closed out by #checkpoints closing song, “Don’t Stop Believin” /it resonates with me - not only because I was born & raised in #Detroit (& NW suburbs) but because songs message - Believin we can #cure #cancer @sitcancer.bsky.social #FinishCancer
Heading 2 #AACR2025 #Chicago to talk about our work on combination #cancer #immunotherapy for #HNSCC & see what is exciting scientists from across the globe. Also looking forward to visiting @loyolachicago.bsky.social Cancer Center to talk with Prof. Michael Nishimura regarding: TCR #FinishCancer
💥 #CELL #THERAPY IN ACTION!! A Diverse & Dynamic group of the people moving the field!! #MoffittBOB #PagonaHealth @iovancebio.bsky.social #Genicity #Galapagos #avencell #Cellares #cancer #immunotherapy #CART #TIL / #Moffitt ROCKS IT with a great program! #SurgeryBranch #NCI #FinishCancer
Dr @patrickhwumd.bsky.social #Moffitt CEO opens #moffittBOB - with statement “This is where the magic will happen” - “How many lives will be saved because of what happens here today!” #FinishCancer #immunotherapy www.ubivac.com #cancer #DarkGenome #DarkMatter #AI
On Day 1 of 2025 want to thank @oncodaily for shout out & share their post. While early, this is promising news for patients with head & neck #cancer #HNSCC /lots of people responsible Drs. Rom Leidner @rbryanbell.bsky.social @walterurba.bsky.social #FinishCancer #UbiVac #Incyte
t.co/bO0JC32H5A
@Aruthak.bsky.social Yes! The #JEDIs are Innovating & JOE YEONG is pulling us together & time not issue 4 this dedicated group still on a hi from #multiomics2024 /10pm #UK, 6am #Singapore & #Taipei, 8am #AU , 2pm #OR #SpatialMedicine #SpatialCatchUps #SpatialInnovation #FinishCancer #cancer
2) Prof Tullia Bruno #B Cell GURU @ #UPMC reviews #TLS & then dives into “DO NOT POST” differences in TLS btwn #melanoma & #LungCancer brain #metastases / #Bridge2024 @sitcancer.bsky.social @robertferrismdphd.bsky.social #FinishCancer
Prof Tullia Bruno #B_Cell GURU @ #UPMC reviews #TLS & then dives into “DO NOT POST” differences in TLS btwn #melanoma & #LungCancer brain #metastases /soon 2 b submitted/ #Bridge2024 @sitcancer.bsky.social @robertferrismdphd.bsky.social #FinishCancer
3) Dr Allison Betof Warner @DrBetofMDPHD #Stanford talks #TIL /The 96% 10 yr survival of TIL pts achieving CR needs us to understand better/the Need for Biopsy
#Bridge2024 #FinishCancer @melanomaau.bsky.social @melanomaresearch.bsky.social @impactmelanoma.bsky.social #MRF @sitcancer.bsky.social
2) Dr Allison Betof Warner @DrBetofMDPHD #Stanford talks #TIL / this post mostly showing #melanoma #Brain #metastases TIL plus future steps /
#Bridge2024 #FinishCancer @melanomaau.bsky.social @melanomaresearch.bsky.social @impactmelanoma.bsky.social #MRF @sitcancer.bsky.social
Dr Allison Betof Warner @DrBetofMDPHD #Stanford talks #TIL / this post mostly showing #melanoma #Brain #metastases TIL plus future steps /
#Bridge2024 #FinishCancer @melanomaau.bsky.social @melanomaresearch.bsky.social @impactmelanoma.bsky.social #MRF @sitcancer.bsky.social
2) Prof Oliver Michelin #spatiomics expert @ Univ de #Geneve & #Swiss #Cancer Center talks graph based methods to assess cell infiltrates. Most data “DO NOT POST” #JoeYeong #JEDIcouncil #Bridge2024 @sitcancer.bsky.social #multiomics @aruthak.bsky.social #USCAP #AI #DigitalPathology #FinishCancer
Prof Oliver Michelin #spatiomics expert @ Univ de #Geneve & #Swiss #Cancer Center talks graph based methods to assess cell infiltrates. Most data “DO NOT POST” #JoeYeong #JEDIcouncil #Bridge2024 @sitcancer.bsky.social #multiomics @aruthak.bsky.social #USCAP #AI #DigitalPathology #FinishCancer
3) GREAT DEBATE! Prof. Ryan Sullivan @danafarber.bsky.social debates with Prof. Olivier Michelin @ #Geneva Univ Cancer Center/ if #IrAE are associated with better outcome! / endocrine & Derm IrAE Strong assoc with response/ #Bridge2024 @sitcancer.bsky.social #cancer #immunotherapy #FinishCancer
Discussion of Prof Mitch Levesque data / Amazing single cell #melanoma phenotypes/ can it explain resistance? Thinks metabolic signature? Functional data more important
#Bridge2024 @melanomaresearch.bsky.social @impactmelanoma.bsky.social @sitcancer.bsky.social #FinishCancer #PAscierto
4) 1) Prof Mitch Levesque #omics expert @ #Uni #Zurich / Amazing #melanoma understanding failure of small molecules / #targeted #therapy/ new tu phenotypes/ sc mel phenotypes/
#Bridge2024 @melanomaresearch.bsky.social @impactmelanoma.bsky.social @sitcancer.bsky.social #FinishCancer #PAscierto
3) Prof Mitch Levesque #omics expert @ #Uni #Zurich / Amazing #melanoma resources available to investigators/#TMA, cell lines, & more / sc mel phenotypes/ talking fast/
#Bridge2024 @melanomaresearch.bsky.social @impactmelanoma.bsky.social @sitcancer.bsky.social #FinishCancer #PAscierto
2) Prof Mitch Levesque #omics expert @ #Uni #Zurich / Amazing #melanoma resources available to investigators/#TMA, cell lines, & more / sc mel phenotypes/ talking fast/
#Bridge2024 @melanomaresearch.bsky.social @impactmelanoma.bsky.social @sitcancer.bsky.social #FinishCancer #PAscierto
1) Prof Mitch Levesque #omics expert @ #Uni #Zurich / Amazing #melanoma resources available to investigators/#TMA, cell lines, & more / sc mel phenotypes/ talking fast/
#Bridge2024 @melanomaresearch.bsky.social @impactmelanoma.bsky.social @sitcancer.bsky.social #FinishCancer #PAscierto
Prof Iman Osman #melanoma #immunotherapy expert @ #NYU #LangoneCancerCenter attacks an unanswered question. What to do with #NF1 mutant melanoma? Great-DO NOT POST DATA #EGFR #BRAF / #BRIDGE2024 #Vivenko @sitcancer.bsky.social @melanomaresearch.bsky.social #FinishCancer #ChilesResearchInstitute
Pt had a Path CR & had CD8 going into tumor. However, same true for nonresponder. NEED TO ID FUNCTIONAL PROPERTIES
3) Prof Michael Postow #melanoma #immunotherapy Expert @mskcancercenter.bsky.social How many doses of #neoadjuvant #IPI #Nivo checkpoint blockade? Can we reduce toxicity & maintain efficacy? @sitcancer.bsky.social #Bridge2024 @impactmelanoma.bsky.social @melanomaresearch.bsky.social #FinishCancer
